The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease is characterized by a widespread functional disturbance of the human brain. Fibrillar amyloid proteins are deposited inside neurons as neurofibrillary tangles and extracellularly as amyloid plaque cores and in blood vessels. The major protein subunit (A4) of the amyloid fibril of tangles, plaques and blood vessel deposits is an insoluble, highly aggregating small polypeptide of relative molecular mass 4,500. The same polypeptide is also deposited in the brains of aged individuals with trisomy 21 (Down's syndrome). We have argued previously that the A4 protein is of neuronal origin and is the cleavage product of a larger precursor protein. To identify this precursor, we have now isolated and sequenced an apparently full-length complementary DNA clone coding for the A4 polypeptide. The predicted precursor consists of 695 residues and contains features characteristic of glycosylated cell-surface receptors. This sequence, together with the localization of its gene on chromosome 21, suggests that the cerebral amyloid deposited in Alzheimer's disease and aged Down's syndrome is caused by aberrant catabolism of a cell-surface receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Molecular imaging studies such as those using amyloid positron emission tomography (PET) have shown that Aβ deposition reaches a plateau before brain atrophy can be identified from structural magnetic resonance imaging (MRI) and cognitive symptoms [15, 19].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [15]
In the citing paper
“All the mutant genes of hereditary, autosomal, and dominant familial AD, including amyloid precursor protein (APP), presenilin 1, and presenilin 2, encode the major proteins involved in amyloid metabolism [14–16].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [15]
In the citing paper
“Amyloid  protein (A), the principal protein in the senile plaques of Alzheimer's disease (AD), is an ϳ4 kDa secreted polypeptide”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Kang et al., 1987
In the citing paper
“APP isoforms are encoded by several alternatively spliced transcripts (Kang et al., 1987;K itaguchi et al., 1988;Ponte et al., 1988;Tanzi et al., 1988;Golde et al., 1990;Ko ¨nig et al., 1992).”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Kang et al., 1987
In the citing paper
“APP, first identified by Kang et al. [18], is a type I transmembrane protein with a long luminal N-terminal domain and a small cytoplasmic C-terminal tail [18,19].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [18]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,401
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Aviv, H., & Leder, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1408 · Cited by 6,751
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Self-citationLehrach, H., Diamond, D., Wozney, J. M., & Boedtker, H. (1977) · Biochemistry · doi:10.1021/bi00640a033 · Cited by 3,415
A gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L. E., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
A cellular gene encodes scrapie PrP 27-30 protein
Oesch, B., Westaway, D., Wälchli, M., McKinley, M. P., Kent, S. B. H., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90333-2 · Cited by 1,513
Research works printed but not linked: 4
- Alzheimer, A. Allg. Z. Psychiat. 64, 146–148 (1907).
- Katzman, R. (ed.) Biological Aspects of Alzheimer's Disease (Banbury Report 15) (Cold Spring Harbor Laboratory, New York, 1983).
- Beyreuther, K. et al. in Discussions in Neuroscience Vol. 3 (eds Bignami, A., Bolis, L. & Gajdusek, D. C. 68–79 Fondation pour I'Étude du Système Nerveux, Geneva (1986).
- Goldgaber, D., Lerman, M. I., McBride, W. O., Sallow, V. & Gajdusek, D. C. Science (in the press).
Cited by
Items 501–600 of 1,071
Yamatsuji, T., Matsui, T., Okamoto, T., Komatsuzaki, K., Takeda, S., Fukumoto, H., Iwatsubo, T., Suzuki, N., Asami-Odaka, A., Ireland, S., et al. (1996) · Science · doi:10.1126/science.272.5266.1349 · Cited by 210
Regulation of β-Amyloid Secretion by FE65, an Amyloid Protein Precursor-binding Protein
Sabo, S. L., Lanier, L. M., Ikin, A. F., Khorkova, O., Sahasrabudhe, S., Greengard, P., & Buxbaum, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7952 · Cited by 209
Structural Models of Amyloid‐Like Fibrils
Nelson, R., & Eisenberg, D. (2006) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(06)73008-x · Cited by 207
Genetics of Alzheimer’s Disease
Chouraki, V., & Seshadri, S. (2014) · Advances in Genetics · doi:10.1016/b978-0-12-800149-3.00005-6 · Cited by 209
Molecular genetics of Alzheimer's disease: An update
Brouwers, N., Sleegers, K., & Van Broeckhoven, C. (2008) · Annals of Medicine · doi:10.1080/07853890802186905 · Cited by 208
“Instrumental here were the observation of AD brain pathology in Down’s syndrome (DS) or trisomy 21 patients (9), the isolation and sequencing of the senile plaque Ab peptide (10), and the mapping of its precursor gene APP (11) near the AD-linked chromosomal region on chromosome 21 (12,13).”
BackgroundDiffuse plaques do not accentuate synapse loss in Alzheimer's disease.
(1990) · Europe PMC (PubMed Central) · Cited by 209
Nordstedt, C., Caporaso, G. L., Thyberg, J., Gandy, S. E., & Greengard, P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54194-6 · Cited by 169
Fluid Biomarkers in Alzheimer Disease
Blennow, K., Zetterberg, H., & Fagan, A. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006221 · Cited by 208
“This breakthrough paved the way for the cloning of the amyloid precursor protein (APP) gene (Kang et al. 1987).”
BackgroundHypomethylation of the amyloid precursor protein gene in the brain of an alzheimer’s disease patient
West, R. L., Lee, J. M., & Maroun, L. E. (1995) · Journal of Molecular Neuroscience · doi:10.1007/bf02736773 · Cited by 208
“The sequence used for analysis was created by joining into one contiguous sequence the APP 5' UTR published by Salbaum et al. (1988), the APP695 sequence ( Kang et al., 1987 ), the exon 7 sequence (Ponte et al., 1988), and the exon 8 sequence (Kitaguchi et al., 1988).”
BackgroundMethodInfluentialYamazaki, T., Selkoe, D. J., & Koo, E. H. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.2.431 · Cited by 208
Van Nostrand, W. E., Wagner, S. L., Shankle, W. R., Farrow, J. S., Dick, M., Rozemuller, J. M., Kuiper, M. A., Wolters, E. C., Zimmerman, J., & Cotman, C. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2551 · Cited by 208
Klyubin, I., Walsh, D. M., Shankar, G. M., Townsend, M., Fadeeva, J. V., Betts, V., Podlisny, M. B., Cleary, J. P., Ashe, K. H., Rowan, M. J., et al. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051087 · Cited by 206
Blennow, K., Bogdanovic, N., Alafuzoff, I., Ekman, R., & Davidsson, P. (1996) · Journal of Neural Transmission · doi:10.1007/bf01273157 · Cited by 206
“The leading hypothesis is that deposition of [3A4 protein, the 39-43 amino acid break-down product of the amyloid precursor protein (Kang et al., 1987), in the microvessels (Glenner et al.”
BackgroundIntramembrane Proteolysis by γ-Secretase
Steiner, H., Fluhrer, R., & Haass, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800010200 · Cited by 206
Narindrasorasak, S., Lowery, D., Gonzalez-DeWhitt, P., Poorman, R. A., Greenberg, B., & Kisilevsky, R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98776-4 · Cited by 207
β-Amyloid and the Pathogenesis of Alzheimer's Disease
Flier, J. S., Underhill, L. H., Yankner, B. A., & Mesulam, M.-M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112263252605 · Cited by 207
Wilhelmus, M. M. M., Boelens, W. C., Otte-Höller, I., Kamps, B., de Waal, R. M. W., & Verbeek, M. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.058 · Cited by 206
A Novel mRNA of the A4 Amyloid Precursor Gene Coding for a Possibly Secreted Protein
de Sauvage, F., & Octave, J.-N. (1989) · Science · doi:10.1126/science.2569763 · Cited by 206
Abe, K., Tanzi, R. E., & Kogure, K. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90020-t · Cited by 205
Swerdlow, R. H. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4149 · Cited by 203
Current Status of Metals as Therapeutic Targets in Alzheimer's Disease
Finefrock, A. E., Bush, A. I., & Doraiswamy, P. M. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51368.x · Cited by 204
Howell, S., Nalbantoglu, J., & Crine, P. (1995) · Peptides · doi:10.1016/0196-9781(95)00021-b · Cited by 204
Miklossy, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00046 · Cited by 203
Functional mitochondria are required for amyloid β‐mediated neurotoxicity
Cardoso, S. M., Santos, S., Swerdlow, R. H., & Oliveira, C. R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0561fje · Cited by 203
“A β 25–35 exposure was also associated with (1) inhibition of mitochondrial respiratory chain complexes (I, NADHubiquinone oxidoreductase; II/III, succinate-cytochrome c oxidoreductase; and IV, cytochrome c oxidase), (2) ATP depletion, and (3) reduction of the mitochondrial membrane potential.”
BackgroundWhat the evolution of the amyloid protein precursor supergene family tells us about its function
Coulson, E. J., Paliga, K., Beyreuther, K., & Masters, C. L. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00125-4 · Cited by 203
Self-citationCaporaso, G. L., Gandy, S. E., Buxbaum, J. D., & Greengard, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2252 · Cited by 203
Harigaya, Y., Saido, T. C., Eckman, C. B., Prada, C.-M., Shoji, M., & Younkin, S. G. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3490 · Cited by 202
Synaptic plasticity in animal models of early Alzheimer's disease
Rowan, M. J., Klyubin, I., Cullen, W. K., & Anwyl, R. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2002.1240 · Cited by 203
“Ab is a 4 kDa peptide of 39–43 amino acids located at the part of APP that spans the transmembrane domain, lying partly outside and partly within the membrane (Glenner & Wong 1984; Kang et al. 1987).”
BackgroundJiang, D., Men, L., Wang, J., Zhang, Y., Chickenyen, S., Wang, Y., & Zhou, F. (2007) · Biochemistry · doi:10.1021/bi700508n · Cited by 202
Amyloid-β and Tau at the Crossroads of Alzheimer’s Disease
Gallardo, G., & Holtzman, D. M. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9358-8_16 · Cited by 198
Moechars, D., Lorent, K., De Strooper, B., Dewachter, I., & Van Leuven, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00468.x · Cited by 201
Emerging roles of pathogens in Alzheimer disease
Miklossy, J. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002006 · Cited by 201
Koo, E. H., Squazzo, S. L., Selkoe, D. J., & Koo, C. H. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.5.991 · Cited by 201
Smith, M. A. (1998) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60607-8 · Cited by 194
Chen, W.-T., Liao, Y.-H., Yu, H.-M., Cheng, I. H., & Chen, Y.-R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177246 · Cited by 199
Sporadic and Familial Cerebral Amyloid Angiopathies
Revesz, T., Holton, J. L., Lashley, T., Plant, G., Rostagno, A., Ghiso, J., & Frangione, B. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00449.x · Cited by 199
Metallothioneins in Brain—The Role in Physiology and Pathology
Aschner, M., Cherian, M. G., Klaassen, C. D., Palmiter, R. D., Erickson, J. C., & Bush, A. I. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8054 · Cited by 200
Perez, R. G., Zheng, H., Van der Ploeg, L. H. T., & Koo, E. H. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-24-09407.1997 · Cited by 252
“b-Amyloid precursor protein (bPP) is a type I integral membrane protein that shares homology with glycosylated membrane receptors (Kang et al., 1987) and is present on the surface of neuronal and glial cells (Shivers et al.”
BackgroundApolipoproteins in the brain: implications for neurological and psychiatric disorders
Elliott, D. A., Weickert, C. S., & Garner, B. (2010) · Clinical Lipidology · doi:10.2217/clp.10.37 · Cited by 194
“ApoA-I has also been demonstrated to bind with the extra-cellular domain of APP (which can be cleaved to produce Aβ [210]), and has been found to co-localize with occasional Aβ plaques in the cortex of AD patients [200,211].”
BackgroundAlzheimer's disease: the lipid connection
Hartmann, T., Kuchenbecker, J., & Grimm, M. O. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04715.x · Cited by 175
“transmembrane domain comprising 23 amino acids (aa) and a small C-terminal cytoplasmic domain (Kang et al., 1987; Younkin, 1991).”
BackgroundTokuda, T., Ikeda, S., Yanagisawa, N., Ihara, Y., & Glenner, G. G. (1991) · Acta Neuropathologica · doi:10.1007/bf00308813 · Cited by 198
“Similarly, ~-protein precursors [26] in serum might leak into the brain parenchyma through a damaged blood-brain barrier [18].”
BackgroundRusso, C., Violani, E., Salis, S., Venezia, V., Dolcini, V., Damonte, G., Benatti, U., D'Arrigo, C., Patrone, E., Carlo, P., et al. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01107.x · Cited by 198
“Ab is generated by proteolytic processing of the b-amyloid precursor protein (APP) (Kang et al. 1987; Selkoe 1998), which is sequentially cleaved by b-secretase at the N-terminus and by c-secretase at the C-terminus of Ab (Haass and Selkoe 1993; Simons et al.”
MethodSheng, J. G., Boop, F. A., Mrak, R. E., & Griffin, W. S. T. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051872.x · Cited by 198
“…β-APP has been localized to synaptic sites in normal brain and is known to interact with cell surface receptors, to activate second messenger systems, to inhibit proteases, to promote cell adhesion, and to regulate cell growth (Kang et al., 1987; Saitoh et al., 1989; Schubert et al., 1991).”
BackgroundRoßner, S. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00044-6 · Cited by 198
Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat
Wakita, H., Tomimoto, H., Akiguchi, I., Matsuo, A., Lin, J.-X., Ihara, M., & McGeer, P.-L. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03223-1 · Cited by 197
Oxidative damage increases with age in a canine model of human brain aging
Head, E., Liu, J., Hagen, T. M., Muggenburg, B. A., Milgram, N. W., Ames, B. N., & Cotman, C. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00969.x · Cited by 196
“The amyloid precursor protein (APP), from which Ab is proteolytically cleaved (Kang et al. 1987), is also vulnerable to oxidative damage and exposing APP to metabolic stress favors the production of amyloidogenic fragments (Gabuzda et al. 1994; Multhaup 1997).”
BackgroundHammad, S. M., Ranganathan, S., Loukinova, E., Twal, W. O., & Argraves, W. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18644 · Cited by 197
Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress
Höhn, A., Tramutola, A., & Cascella, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5497046 · Cited by 192
“Mutations in three causal genes, the APP gene on chromosome 21 [106], the PSEN1 gene on chromosome 14 [107], and PSEN2 gene on chromosome 1 [108], have been identified so far.”
BackgroundCholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
Dai, L., Zou, L., Meng, L., Qiang, G., Yan, M., & Zhang, Z. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02232-6 · Cited by 194
Maggio, J. E., Stimson, E. R., Ghilardi, J. R., Allen, C. J., Dahl, C. E., Whitcomb, D. C., Vigna, S. R., Vinters, H. V., Labenski, M. E., & Mantyh, P. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5462 · Cited by 196
Tanzi, R. E., Vaula, G., Romano, D., Mortilla, M., Huang, T., Tupler, R. G., Wasco, W., Hyman, B. T., Haines, J. L., & Jenkins, B. (1992) · PubMed Central · Cited by 208
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease
Andreasen, N., & Blennow, K. (2005) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2004.10.011 · Cited by 193
Schubert, D., LaCorbiere, M., Saitoh, T., & Cole, G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.6.2066 · Cited by 195
Sennvik, K., Fastbom, J., Blomberg, M., Wahlund, L.-O., Winblad, B., & Benedikz, E. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00929-5 · Cited by 193
Cognitive Impairment: Dementia and Alzheimer's Disease
Larson, E. B., Kukull, W. A., & Katzman, R. L. (1992) · Annual Review of Public Health · doi:10.1146/annurev.pu.13.050192.002243 · Cited by 192
Sprecher, C. A., Grant, F. J., Grimm, G., O'Hara, P. J., Norris, F., Norris, K., & Foster, D. C. (1993) · Biochemistry · doi:10.1021/bi00068a002 · Cited by 193
Gralle, M., & Ferreira, S. T. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.02.001 · Cited by 191
Weggen, S., & Beher, D. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt107 · Cited by 192
Prions and Neurodegenerative Diseases
Epstein, F. H., & Prusiner, S. B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712173172505 · Cited by 192
Animal models of Alzheimer's disease and evaluation of anti-dementia drugs
Yamada, K., & Nabeshima, T. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00081-4 · Cited by 190
Lee, J.-Y., Friedman, J. E., Angel, I., Kozak, A., & Koh, J.-Y. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.01.005 · Cited by 191
The Zinc Finger Protein CTCF Binds to the APBβ Domain of the Amyloid β-Protein Precursor Promoter
Vostrov, A. A., & Quitschke, W. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33353 · Cited by 191
Kim, W. S., Rahmanto, A. S., Kamili, A., Rye, K.-A., Guillemin, G. J., Gelissen, I. C., Jessup, W., Hill, A. F., & Garner, B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607831200 · Cited by 191
Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes
MIKLOSSY, J., KIS, A., RADENOVIC, A., MILLER, L., FORRO, L., MARTINS, R., REISS, K., DARBINIAN, N., DAREKAR, P., & MIHALY, L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.018 · Cited by 189
“The amyloid substance that accumulates in the brain is a 4 kDa peptide (A!), which is derived by proteolytic cleavage of amyloid beta precursor protein (A!PP) [16].”
BackgroundInflammatory processes induce beta-amyloid precursor protein changes in mouse brain.
Brugg, B., Dubreuil, Y. L., Huber, G., Wollman, E. E., Delhaye-Bouchaud, N., & Mariani, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3032 · Cited by 192
Amyloidosis and Alzheimer’s disease
Ghiso, J., & Frangione, B. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00149-7 · Cited by 158
Yamaguchi, H., Yamazaki, T., Lemere, C. A., Frosch, M. P., & Selkoe, D. J. (1992) · PubMed · Cited by 216
Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes
Moreira, P. I., Santos, M. S., Seiça, R., & Oliveira, C. R. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.017 · Cited by 189
“Similarly to Aβ peptide, IAPP spontaneously forms into amyloid aggregates in an aqueous environment [11].”
BackgroundInfluentialAmyloid β Protein Precursor Is Possibly a Heparan Sulfate Proteoglycan Core Protein
Schubert, D., Schroeder, R., LaCorbiere, M., Saitoh, T., & Cole, G. (1988) · Science · doi:10.1126/science.2968652 · Cited by 190
Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques
Ginsberg, S. D., Crino, P. B., Lee, V. M. ‐., Eberwine, J. H., & Trojanowski, J. Q. (1997) · Annals of Neurology · doi:10.1002/ana.410410211 · Cited by 189
Tomita, S., Kirino, Y., & Suzuki, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6277 · Cited by 189
Näslund, J., Thyberg, J., Tjernberg, L. O., Wernstedt, C., Karlström, A. R., Bogdanovic, N., Gandy, S. E., Lannfelt, L., Terenius, L., & Nordstedt, C. (1995) · Neuron · doi:10.1016/0896-6273(95)90079-9 · Cited by 189
The Alzheimer’s Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease
Stakos, D. A., Stamatelopoulos, K., Bampatsias, D., Sachse, M., Zormpas, E., Vlachogiannis, N. I., Tual-Chalot, S., & Stellos, K. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.033 · Cited by 188
“Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins.”
BackgroundInfluentialArendt, T. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.007 · Cited by 188
Kienlen-Campard, P., Miolet, S., Tasiaux, B., & Octave, J.-N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200887200 · Cited by 187
McDermott, J. R., & Gibson, A. M. (1997) · Neurochemical Research · doi:10.1023/a:1027325304203 · Cited by 187
β-Amyloid protein promotes neuritic branching in hippocampal cultures
Whitson, J. S., Glabe, C. G., Shintani, E., Abcar, A., & Cotman, C. W. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90867-9 · Cited by 187
Biology of Aβ Amyloid in Alzheimer's Disease
Wisniewski, T., Ghiso, J., & Frangione, B. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0147 · Cited by 134
Marcinkiewicz, M., & Seidah, N. G. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752133.x · Cited by 186
Singh, S. K., Srivastav, S., Yadav, A. K., Srikrishna, S., & Perry, G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7361613 · Cited by 186
“Furthermore, cloning of the AβPP gene [35] has allowed the disease to be examined at molecular and biochemical levels.”
BackgroundThe β-Secretase, BACE: A Prime Drug Target for Alzheimer's Disease
Vassar, R. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:157 · Cited by 186
“Ar obust genetic association exists between earlyonset familial forms of AD (FAD) and the 42 amino acid species of the Aβ peptide (Aβ42) (reviewed in Hutton et al., 1998; Sisodia et al., 1999; Younkin, 1998).”
BackgroundAdvances in the Cellular and Molecular Biology of the Beta-Amyloid Protein in Alzheimer 's Disease
Sambamurti, K., Greig, N. H., & Lahiri, D. K. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:1:1:1 · Cited by 185
Disabled-1 Binds to the Cytoplasmic Domain of Amyloid Precursor-Like Protein 1
Homayouni, R., Rice, D. S., Sheldon, M., & Curran, T. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07507.1999 · Cited by 185
“All APP-like proteins bind to Dab1 APLP1 is a member of the family of proteins including APP (Kang et al., 1987) and APLP2 (Wasco et al., 1993).”
BackgroundKang, J., & Müller-Hill, B. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90992-v · Cited by 185
Self-citationCohen, M. L., Golde, T. E., Usiak, M. F., Younkin, L. H., & Younkin, S. G. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1227 · Cited by 185
Neuronal Cell Death in Alzheimers Disease and a Neuroprotective Factor, Humanin
Niikura, T., Tajima, H., & Kita, Y. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359577 · Cited by 184
“We used the London-type APP mutant, V642I-APP as the AD-specific insult [59], since the expression of V642I-APP induces cell death in neuronal cell lines and primary cortical neurons in vitro [15,23,47,59, 60,64,85,87,92].”
BackgroundInfluentialMatsuda, S., Yasukawa, T., Homma, Y., Ito, Y., Niikura, T., Hiraki, T., Hirai, S., Ohno, S., Kita, Y., Kawasumi, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06597.2001 · Cited by 184
“Consistently, considerable amounts of APP are found on the surface of neurons ( Jung et al., 1996; Brouillet et al., 1999; Sudo et al., 2000).”
Backgroundbeta-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin.
Kibbey, M. C., Jucker, M., Weeks, B. S., Neve, R. L., Van Nostrand, W. E., & Kleinman, H. K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10150 · Cited by 184
Buxbaum, J. D., Ruefli, A. A., Parker, C. A., Cypess, A. M., & Greengard, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4489 · Cited by 184
Effects of in vivo conditions on amyloid aggregation
Owen, M. C., Gnutt, D., Gao, M., Wärmländer, S. K. T. S., Jarvet, J., Gräslund, A., Winter, R., Ebbinghaus, S., & Strodel, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00034d · Cited by 182
Role of microglia in senile plaque formation
Mackenzie, I. R. A., Hao, C., & Munoz, D. G. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00092-s · Cited by 183
Chondroitin Sulfate Proteoglycans Are Associated with the Lesions of Alzheimer's Disease
DeWitt, D. A., Silver, J., Canning, D. R., & Perry, G. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1081 · Cited by 182
Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein.
Davis, J., & Van Nostrand, W. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2996 · Cited by 182
Güntert, A., Döbeli, H., & Bohrmann, B. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.027 · Cited by 181
Simons, M., de Strooper, B., Multhaup, G., Tienari, P., Dotti, C., & Beyreuther, K. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-03-00899.1996 · Cited by 181
Self-citationJoachim, C. L., Duffy, L. K., Morris, J. H., & Selkoe, D. J. (1988) · Brain Research · doi:10.1016/0006-8993(88)90673-7 · Cited by 180
A β 42 and A β 40: similarities and differences
Qiu, T., Liu, Q., Chen, Y., Zhao, Y., & Li, Y. (2015) · Journal of Peptide Science · doi:10.1002/psc.2789 · Cited by 180
Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors.
Lee, R. K., Wurtman, R. J., Cox, A. J., & Nitsch, R. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.8083 · Cited by 179
Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease.
Gearing, M., Rebeck, G. W., Hyman, B. T., Tigges, J., & Mirra, S. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9382 · Cited by 179
Loureiro, J. A., Gomes, B., Fricker, G., Coelho, M. A. N., Rocha, S., & Pereira, M. C. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.04.041 · Cited by 179
Metadata
- Authors
- Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B.
- Affiliations
- University of Cologne (DE)
- Venue
- Nature
- Published
- 1987-02
- Volume
- 325
- Issue
- 6106
- Pages
- 733-736
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2081881251
- Cited by
- 4,619
- References
- 26
- Citations by year
- 2026: 38 · 2025: 58 · 2024: 63 · 2023: 71 · 2022: 54 · 2021: 79 · 2020: 82 · 2019: 76 · 2018: 76 · 2017: 98 · 2016: 111 · 2015: 90 · 2014: 97 · 2013: 119 · 2012: 126
- FWCI
- 164.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid precursor protein, cell surface receptors, Down syndrome, amyloid plaques, neurofibrillary tangles, chromosome 21, cDNA cloning, protein sequences
- MeSH terms
- Alzheimer Disease, Amyloid, Base Sequence, Brain, Brain Chemistry, Chromosomes, Human, Pair 21, DNA, Down Syndrome, Fetus, Humans, Neurofibrils, Nucleic Acid Hybridization, Protein Precursors, Protein Processing, Post-Translational, RNA, Messenger, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.